IROQ vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IROQ presents as a classic value play, trading below its Graham Number ($31.52) and Intrinsic Value ($31.90) with a Price-to-Book ratio of 0.99. However, a Piotroski F-Score of 4/9 indicates only stable financial health, and the technical trend is currently bearish (0/100). While revenue and earnings growth remain positive at approximately 8%, the low ROE (6.33%) and ROA (0.60%) suggest inefficient capital utilization. The lack of analyst coverage and negligible dividend yield further temper the bullish value case.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
IROQ vs JPM: Head-to-Head Comparison
This page compares IF Bancorp Inc (IROQ) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.